Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (107 total)
-
Autor: Normand, Sharon-Lise T.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-21
Descripción: In a platform trial, patients with a single disease are randomly assigned to a group of different therapies on the basis of a decision algorithm to determine whether any therapy has benefit. -
Autor: NIH
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-02-10
Descripción: In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (2019-nCoV) from these pneumonia patients… -
Autor: NIH
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2020-02-05
Descripción: In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coronavirus (2019-nCoV) from these pneumonia patients… -
Autor: NIH
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2019-08-12
Descripción: The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20,… -
Autor: NETEC SPRN Medical Countermeasures Working Group
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019-02-19
Descripción: Emerging and re-emerging infectious diseases pose growing global public health threats. However, research on and development of medical countermeasures (MCMs) for such pathogens is limited by the sporadic and unpredictable nature of outbreaks, lack… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Hipervínculo
Fecha de actualización: 2023-02-24
Descripción: This NETEC blog post reviews 10 Takeaways for Clinicians for Marburg Virus Disease (MVD), MVD Therapeutics and Vaccine Candidates, and additional resources. -
Autor: NETEC
Tema: Emergency Management
Tipo de elemento: Webinar
Fecha de actualización: 2022-11-09
Descripción: This NETEC webinar will discuss the current landscape of influenza in the United States and the predictions for this year’s flu season. Additional topics will include available therapeutics to treat common symptoms and co-infections and infection… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2020-12-10
Descripción: This printable flyer infographic discusses mAb for COVID-19. Monoclonal antibody therapeutics (mAb) are one of the first available medical countermeasure therapeutics for mild-to-moderate COVID-19 cases. This handout discusses what they are, the… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Webinar
Fecha de actualización: 2020-11-25
Descripción: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…